Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Complement Membrane Attack Complex | 20 | 2024 | 105 | 2.180 |
Why?
|
Diabetes, Gestational | 9 | 2024 | 1263 | 1.980 |
Why?
|
Glucose Intolerance | 5 | 2024 | 579 | 1.910 |
Why?
|
Eukaryotic Initiation Factor-2 | 11 | 2019 | 178 | 1.580 |
Why?
|
Complement System Proteins | 14 | 2015 | 738 | 1.270 |
Why?
|
Diabetic Angiopathies | 4 | 2016 | 806 | 0.990 |
Why?
|
Complement Activation | 12 | 2024 | 447 | 0.940 |
Why?
|
Peptide Chain Initiation, Translational | 3 | 2013 | 100 | 0.910 |
Why?
|
Eicosapentaenoic Acid | 3 | 2015 | 565 | 0.830 |
Why?
|
Thiazoles | 8 | 2014 | 1542 | 0.800 |
Why?
|
Thiazolidinediones | 4 | 2013 | 461 | 0.730 |
Why?
|
Protein Biosynthesis | 11 | 2013 | 2094 | 0.720 |
Why?
|
Clotrimazole | 3 | 2013 | 76 | 0.720 |
Why?
|
Erythrocytes | 11 | 2017 | 2421 | 0.690 |
Why?
|
Infant, Newborn, Diseases | 2 | 2022 | 587 | 0.680 |
Why?
|
Chromans | 2 | 2013 | 116 | 0.660 |
Why?
|
Hypoglycemia | 2 | 2024 | 895 | 0.630 |
Why?
|
Blood Glucose | 12 | 2024 | 6435 | 0.620 |
Why?
|
Erythrocyte Membrane | 10 | 2017 | 438 | 0.600 |
Why?
|
Antineoplastic Agents | 16 | 2019 | 13698 | 0.590 |
Why?
|
Fetal Diseases | 1 | 2022 | 916 | 0.560 |
Why?
|
Hydrazones | 6 | 2014 | 105 | 0.560 |
Why?
|
Histidine | 1 | 2017 | 302 | 0.540 |
Why?
|
Platelet Activation | 4 | 2010 | 644 | 0.540 |
Why?
|
Eukaryotic Initiation Factor-4G | 5 | 2014 | 68 | 0.510 |
Why?
|
RNA, Transfer, Met | 1 | 2015 | 14 | 0.500 |
Why?
|
Postpartum Period | 2 | 2023 | 1198 | 0.500 |
Why?
|
Urea | 5 | 2019 | 448 | 0.490 |
Why?
|
Indoles | 3 | 2012 | 1836 | 0.490 |
Why?
|
Nitro Compounds | 2 | 2012 | 74 | 0.480 |
Why?
|
Guanosine Triphosphate | 1 | 2015 | 315 | 0.460 |
Why?
|
Glucose Tolerance Test | 5 | 2024 | 1183 | 0.450 |
Why?
|
Complement C3 | 4 | 2024 | 434 | 0.450 |
Why?
|
Eukaryotic Initiation Factor-4E | 5 | 2014 | 112 | 0.450 |
Why?
|
Phosphorylation | 13 | 2019 | 8317 | 0.410 |
Why?
|
Glycosylation | 6 | 2020 | 1101 | 0.410 |
Why?
|
Hemolysis | 6 | 2017 | 417 | 0.410 |
Why?
|
Endothelium, Vascular | 7 | 2016 | 4428 | 0.400 |
Why?
|
Eukaryotic Initiation Factor-4F | 1 | 2012 | 42 | 0.400 |
Why?
|
Apolipoproteins E | 3 | 2016 | 1461 | 0.380 |
Why?
|
Hemoglobinuria, Paroxysmal | 2 | 2009 | 96 | 0.380 |
Why?
|
Fish Oils | 1 | 2015 | 483 | 0.370 |
Why?
|
Calcium | 15 | 2004 | 5792 | 0.360 |
Why?
|
5' Untranslated Regions | 2 | 2015 | 255 | 0.340 |
Why?
|
Mice, Knockout | 10 | 2024 | 14484 | 0.330 |
Why?
|
Oligospermia | 1 | 2009 | 59 | 0.320 |
Why?
|
Anemia, Hemolytic, Congenital | 1 | 2009 | 71 | 0.310 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 7 | 1991 | 480 | 0.310 |
Why?
|
BRCA1 Protein | 1 | 2015 | 1156 | 0.300 |
Why?
|
Structure-Activity Relationship | 11 | 2019 | 3057 | 0.290 |
Why?
|
Bacteriocins | 4 | 2011 | 85 | 0.270 |
Why?
|
Thrombophilia | 1 | 2009 | 308 | 0.260 |
Why?
|
eIF-2 Kinase | 3 | 2013 | 147 | 0.260 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2021 | 3447 | 0.260 |
Why?
|
Gene Knockout Techniques | 1 | 2009 | 808 | 0.250 |
Why?
|
Anemia, Hemolytic | 2 | 2005 | 164 | 0.250 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 11932 | 0.250 |
Why?
|
Mice | 32 | 2024 | 82072 | 0.240 |
Why?
|
Thiones | 1 | 2004 | 51 | 0.240 |
Why?
|
Potassium | 10 | 1993 | 1315 | 0.240 |
Why?
|
RNA Cap Analogs | 1 | 2004 | 13 | 0.230 |
Why?
|
Animals | 49 | 2024 | 169335 | 0.230 |
Why?
|
Nitric Oxide | 3 | 2010 | 2149 | 0.230 |
Why?
|
Pregnancy | 10 | 2024 | 30265 | 0.220 |
Why?
|
Sodium | 10 | 1993 | 1597 | 0.220 |
Why?
|
Fluorescein | 1 | 2004 | 175 | 0.220 |
Why?
|
Infertility, Male | 2 | 2005 | 398 | 0.220 |
Why?
|
Cell Line, Tumor | 14 | 2019 | 17173 | 0.210 |
Why?
|
Receptors, Complement | 1 | 2004 | 254 | 0.210 |
Why?
|
Myasthenia Gravis, Autoimmune, Experimental | 2 | 2012 | 7 | 0.210 |
Why?
|
Cell Division | 5 | 2001 | 4478 | 0.200 |
Why?
|
Atherosclerosis | 2 | 2016 | 3431 | 0.200 |
Why?
|
Crosses, Genetic | 2 | 2016 | 752 | 0.190 |
Why?
|
Cell Membrane Permeability | 4 | 1993 | 573 | 0.190 |
Why?
|
Mice, Inbred DBA | 3 | 2013 | 624 | 0.190 |
Why?
|
Reproduction | 1 | 2005 | 646 | 0.180 |
Why?
|
Complement C5 | 3 | 2024 | 104 | 0.180 |
Why?
|
Mice, Nude | 4 | 2015 | 3631 | 0.170 |
Why?
|
Cell Proliferation | 10 | 2019 | 10486 | 0.170 |
Why?
|
3T3 Cells | 5 | 2001 | 1085 | 0.170 |
Why?
|
Fetal Macrosomia | 1 | 2020 | 138 | 0.160 |
Why?
|
Ion Channels | 3 | 1990 | 1043 | 0.160 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 696 | 0.160 |
Why?
|
Aniline Compounds | 1 | 2004 | 1095 | 0.160 |
Why?
|
Glucose | 5 | 2022 | 4352 | 0.150 |
Why?
|
Parity | 1 | 2021 | 931 | 0.150 |
Why?
|
Blood Platelets | 1 | 2009 | 2479 | 0.150 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14752 | 0.150 |
Why?
|
Humans | 64 | 2024 | 768970 | 0.150 |
Why?
|
Digitalis | 2 | 1989 | 14 | 0.150 |
Why?
|
Infant, Newborn | 6 | 2024 | 26428 | 0.150 |
Why?
|
Heme | 1 | 2019 | 316 | 0.150 |
Why?
|
Plants, Toxic | 2 | 1989 | 70 | 0.140 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2013 | 3621 | 0.140 |
Why?
|
Area Under Curve | 1 | 2021 | 1645 | 0.140 |
Why?
|
Drug Screening Assays, Antitumor | 4 | 2019 | 719 | 0.140 |
Why?
|
Plants, Medicinal | 2 | 1989 | 167 | 0.140 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 859 | 0.140 |
Why?
|
Cyclin D1 | 2 | 2013 | 453 | 0.130 |
Why?
|
Streptozocin | 1 | 2016 | 190 | 0.130 |
Why?
|
Breast Neoplasms | 2 | 2015 | 21188 | 0.130 |
Why?
|
Female | 23 | 2024 | 397515 | 0.130 |
Why?
|
Fibroblast Growth Factor 2 | 2 | 1996 | 594 | 0.130 |
Why?
|
Vascular Diseases | 1 | 2004 | 1163 | 0.120 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2004 | 1399 | 0.120 |
Why?
|
Rats | 12 | 2013 | 23786 | 0.120 |
Why?
|
Melanoma | 2 | 2012 | 5709 | 0.120 |
Why?
|
Sulfonamides | 1 | 2004 | 1981 | 0.120 |
Why?
|
Cerebrospinal Fluid | 2 | 1989 | 545 | 0.120 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 5801 | 0.120 |
Why?
|
Platelet-Derived Growth Factor | 2 | 1994 | 617 | 0.120 |
Why?
|
Neoplasm Transplantation | 2 | 2015 | 2018 | 0.120 |
Why?
|
Complement C9 | 3 | 2009 | 15 | 0.110 |
Why?
|
Growth Inhibitors | 1 | 1995 | 375 | 0.110 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2014 | 73 | 0.110 |
Why?
|
Enzyme Activators | 1 | 2013 | 56 | 0.110 |
Why?
|
Macrophage Activation | 1 | 2016 | 556 | 0.110 |
Why?
|
Neuromuscular Junction | 2 | 2012 | 407 | 0.110 |
Why?
|
Models, Molecular | 7 | 2019 | 5404 | 0.110 |
Why?
|
Mice, Inbred Strains | 2 | 2009 | 1769 | 0.100 |
Why?
|
Molecular Structure | 5 | 2019 | 1885 | 0.100 |
Why?
|
Lysine | 1 | 2017 | 1000 | 0.100 |
Why?
|
Papillary Muscles | 1 | 1993 | 192 | 0.100 |
Why?
|
Tumor Cells, Cultured | 6 | 2011 | 6131 | 0.100 |
Why?
|
Ireland | 2 | 2022 | 170 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2014 | 12253 | 0.100 |
Why?
|
Testis | 2 | 2006 | 784 | 0.100 |
Why?
|
RNA, Messenger | 4 | 2015 | 12806 | 0.100 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22379 | 0.100 |
Why?
|
Indazoles | 1 | 2014 | 306 | 0.100 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18354 | 0.100 |
Why?
|
Prospective Studies | 5 | 2023 | 54962 | 0.100 |
Why?
|
Gestational Age | 2 | 2020 | 3621 | 0.100 |
Why?
|
Calcium Channel Blockers | 1 | 1995 | 691 | 0.100 |
Why?
|
Open Reading Frames | 1 | 2015 | 818 | 0.100 |
Why?
|
Mice, Transgenic | 5 | 2017 | 9565 | 0.100 |
Why?
|
Case-Control Studies | 2 | 2021 | 22296 | 0.090 |
Why?
|
Peptides | 4 | 2014 | 4353 | 0.090 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2014 | 296 | 0.090 |
Why?
|
Aorta | 2 | 2016 | 2046 | 0.090 |
Why?
|
Ouabain | 5 | 1989 | 246 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2019 | 10765 | 0.090 |
Why?
|
Biological Transport | 6 | 1996 | 2085 | 0.090 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2017 | 1124 | 0.090 |
Why?
|
Potassium Channels | 3 | 1993 | 538 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2017 | 1320 | 0.090 |
Why?
|
Spermatozoa | 2 | 2005 | 632 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2012 | 2848 | 0.090 |
Why?
|
Molecular Mimicry | 2 | 2014 | 213 | 0.080 |
Why?
|
Exons | 2 | 2009 | 2395 | 0.080 |
Why?
|
S-Nitroso-N-Acetylpenicillamine | 1 | 2009 | 23 | 0.080 |
Why?
|
Prenatal Care | 1 | 2017 | 1162 | 0.080 |
Why?
|
Nitroso Compounds | 1 | 2009 | 71 | 0.080 |
Why?
|
Complement Pathway, Classical | 1 | 2009 | 91 | 0.080 |
Why?
|
Guinea Pigs | 3 | 2000 | 1309 | 0.080 |
Why?
|
Random Allocation | 1 | 2013 | 2394 | 0.080 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2009 | 125 | 0.080 |
Why?
|
Nitric Oxide Donors | 1 | 2009 | 126 | 0.080 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2009 | 262 | 0.080 |
Why?
|
Infant | 3 | 2022 | 36556 | 0.080 |
Why?
|
Kinetics | 6 | 1994 | 6332 | 0.080 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2009 | 424 | 0.080 |
Why?
|
Azides | 1 | 2008 | 120 | 0.070 |
Why?
|
CHO Cells | 2 | 2001 | 1379 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1904 | 0.070 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 1988 | 71 | 0.070 |
Why?
|
Complement Inactivator Proteins | 3 | 2000 | 74 | 0.070 |
Why?
|
Pregnant Women | 2 | 2022 | 576 | 0.070 |
Why?
|
Transfection | 3 | 2000 | 5763 | 0.070 |
Why?
|
Intracranial Pressure | 1 | 1989 | 325 | 0.070 |
Why?
|
Alkynes | 1 | 2008 | 327 | 0.070 |
Why?
|
Cricetinae | 2 | 2001 | 2423 | 0.070 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2011 | 1356 | 0.070 |
Why?
|
Sodium Chloride | 4 | 1989 | 584 | 0.070 |
Why?
|
Molecular Sequence Data | 6 | 2009 | 17629 | 0.070 |
Why?
|
Adaptive Immunity | 1 | 2012 | 733 | 0.070 |
Why?
|
Umbilical Veins | 2 | 2000 | 425 | 0.070 |
Why?
|
Cell Line | 6 | 2013 | 15604 | 0.070 |
Why?
|
Hydrogen | 1 | 2007 | 171 | 0.070 |
Why?
|
RNA Interference | 1 | 2015 | 2835 | 0.070 |
Why?
|
Sperm Capacitation | 1 | 2005 | 21 | 0.060 |
Why?
|
Nitric Oxide Synthase | 1 | 2009 | 911 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3813 | 0.060 |
Why?
|
Peptides, Cyclic | 1 | 2008 | 391 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2004 | 5892 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2020 | 2974 | 0.060 |
Why?
|
Male | 19 | 2024 | 365203 | 0.060 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2006 | 294 | 0.060 |
Why?
|
Neoplasms, Experimental | 2 | 2001 | 1231 | 0.060 |
Why?
|
Membrane Potentials | 4 | 1993 | 1090 | 0.060 |
Why?
|
Cell Membrane | 2 | 2012 | 3659 | 0.060 |
Why?
|
Carbon | 2 | 2007 | 672 | 0.060 |
Why?
|
Recombinant Proteins | 4 | 2011 | 6512 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15471 | 0.060 |
Why?
|
Growth Substances | 1 | 1987 | 760 | 0.060 |
Why?
|
Rubidium | 4 | 1991 | 121 | 0.060 |
Why?
|
Proteins | 2 | 2009 | 6011 | 0.060 |
Why?
|
Fluorescence Polarization | 1 | 2004 | 139 | 0.060 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2014 | 3782 | 0.060 |
Why?
|
Protein Binding | 4 | 2014 | 9344 | 0.060 |
Why?
|
Signal Transduction | 3 | 2010 | 23653 | 0.050 |
Why?
|
Extracellular Space | 1 | 1985 | 565 | 0.050 |
Why?
|
Young Adult | 3 | 2021 | 60131 | 0.050 |
Why?
|
Stereoisomerism | 2 | 2014 | 611 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2004 | 1065 | 0.050 |
Why?
|
Mast Cells | 3 | 1979 | 1406 | 0.050 |
Why?
|
Thirst | 2 | 1979 | 42 | 0.050 |
Why?
|
Cyclin G | 1 | 2001 | 7 | 0.050 |
Why?
|
Cyclin G1 | 1 | 2001 | 15 | 0.050 |
Why?
|
Amino Acid Sequence | 5 | 2009 | 13427 | 0.050 |
Why?
|
Transcription Factors | 1 | 2001 | 12174 | 0.050 |
Why?
|
Adult | 6 | 2024 | 223851 | 0.050 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2004 | 414 | 0.050 |
Why?
|
Sperm Motility | 1 | 2003 | 266 | 0.050 |
Why?
|
Proteinuria | 1 | 2004 | 610 | 0.050 |
Why?
|
Pulmonary Artery | 1 | 2010 | 1945 | 0.050 |
Why?
|
Receptors, Cholinergic | 2 | 2012 | 244 | 0.050 |
Why?
|
Ligands | 2 | 2014 | 3283 | 0.050 |
Why?
|
Tyrosine | 1 | 2005 | 1427 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2009 | 2203 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 1966 | 0.050 |
Why?
|
Alternative Splicing | 1 | 2006 | 1105 | 0.040 |
Why?
|
Pregnancy Outcome | 2 | 2022 | 2974 | 0.040 |
Why?
|
Dehydration | 2 | 1979 | 216 | 0.040 |
Why?
|
Liposomes | 2 | 1996 | 793 | 0.040 |
Why?
|
Ribose | 1 | 2000 | 63 | 0.040 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2010 | 1252 | 0.040 |
Why?
|
Phenotype | 3 | 2009 | 16731 | 0.040 |
Why?
|
Triazoles | 1 | 2005 | 904 | 0.040 |
Why?
|
Cyclin E | 1 | 2000 | 156 | 0.040 |
Why?
|
Ploidies | 1 | 2000 | 287 | 0.040 |
Why?
|
Heparin | 1 | 1987 | 1636 | 0.040 |
Why?
|
Organ Specificity | 2 | 2001 | 1970 | 0.040 |
Why?
|
Prostaglandins E | 1 | 1979 | 166 | 0.040 |
Why?
|
Vasculitis | 1 | 2004 | 525 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2007 | 19023 | 0.040 |
Why?
|
Insulin | 1 | 2014 | 6610 | 0.040 |
Why?
|
Hypertension, Pulmonary | 1 | 2010 | 1601 | 0.040 |
Why?
|
Water Deprivation | 1 | 1978 | 19 | 0.040 |
Why?
|
Cyclins | 1 | 2001 | 606 | 0.040 |
Why?
|
G1 Phase | 1 | 2000 | 403 | 0.040 |
Why?
|
Histamine | 2 | 1978 | 496 | 0.040 |
Why?
|
Cyclization | 2 | 2009 | 59 | 0.040 |
Why?
|
Cattle | 2 | 1995 | 3819 | 0.040 |
Why?
|
Creatinine | 1 | 2004 | 1917 | 0.040 |
Why?
|
Ubiquitins | 1 | 2000 | 366 | 0.040 |
Why?
|
Introns | 1 | 2001 | 969 | 0.040 |
Why?
|
Down-Regulation | 1 | 2006 | 2942 | 0.040 |
Why?
|
Cohort Studies | 1 | 2021 | 41808 | 0.040 |
Why?
|
Electrophysiology | 2 | 1993 | 1266 | 0.040 |
Why?
|
Base Sequence | 3 | 2006 | 12430 | 0.040 |
Why?
|
K562 Cells | 1 | 2000 | 648 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 1989 | 3726 | 0.040 |
Why?
|
Endoplasmic Reticulum | 1 | 2004 | 1133 | 0.040 |
Why?
|
Cloning, Molecular | 2 | 2000 | 4168 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2022 | 917 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5864 | 0.040 |
Why?
|
Time Factors | 6 | 2009 | 40261 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2004 | 973 | 0.040 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2021 | 475 | 0.040 |
Why?
|
Permeability | 2 | 1989 | 726 | 0.030 |
Why?
|
Drinking Behavior | 1 | 1977 | 103 | 0.030 |
Why?
|
Saline Solution, Hypertonic | 1 | 1977 | 115 | 0.030 |
Why?
|
Sheep | 2 | 1990 | 1451 | 0.030 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1996 | 222 | 0.030 |
Why?
|
Molecular Weight | 2 | 1989 | 2173 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2004 | 1933 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2001 | 1748 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2000 | 2179 | 0.030 |
Why?
|
Carrier Proteins | 1 | 1989 | 4939 | 0.030 |
Why?
|
Umbilical Cord | 1 | 1996 | 179 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2001 | 2525 | 0.030 |
Why?
|
Adolescent | 2 | 2014 | 89244 | 0.030 |
Why?
|
Intracellular Fluid | 1 | 1995 | 201 | 0.030 |
Why?
|
Capillary Permeability | 1 | 1978 | 773 | 0.030 |
Why?
|
ras Proteins | 1 | 2000 | 1058 | 0.030 |
Why?
|
Dextrans | 1 | 1996 | 574 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2009 | 1536 | 0.030 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 2 | 2008 | 508 | 0.030 |
Why?
|
Cell Compartmentation | 1 | 1995 | 383 | 0.030 |
Why?
|
Bacterial Proteins | 1 | 2007 | 3840 | 0.030 |
Why?
|
RNA Caps | 1 | 2014 | 73 | 0.030 |
Why?
|
Mutation | 2 | 2017 | 30266 | 0.030 |
Why?
|
Birth Weight | 1 | 2022 | 2121 | 0.030 |
Why?
|
Genotype | 1 | 2009 | 13048 | 0.030 |
Why?
|
Glomerular Mesangium | 1 | 1994 | 98 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2017 | 559 | 0.030 |
Why?
|
Antigens, CD | 1 | 2004 | 4032 | 0.030 |
Why?
|
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1991 | 33 | 0.030 |
Why?
|
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1991 | 59 | 0.030 |
Why?
|
Solutions | 1 | 2014 | 410 | 0.030 |
Why?
|
Mothers | 1 | 2024 | 2209 | 0.030 |
Why?
|
Complement C5b | 1 | 1993 | 9 | 0.030 |
Why?
|
Charybdotoxin | 1 | 1993 | 23 | 0.030 |
Why?
|
Protein Structure, Quaternary | 1 | 2014 | 426 | 0.030 |
Why?
|
Scorpion Venoms | 1 | 1993 | 30 | 0.030 |
Why?
|
Thymidine | 1 | 1993 | 297 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2001 | 4625 | 0.030 |
Why?
|
Mitogens | 1 | 1993 | 229 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2014 | 424 | 0.030 |
Why?
|
Rabbits | 2 | 2009 | 4774 | 0.030 |
Why?
|
Zymosan | 1 | 1993 | 134 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2013 | 466 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1996 | 1251 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 1994 | 521 | 0.030 |
Why?
|
Electric Conductivity | 2 | 1991 | 408 | 0.030 |
Why?
|
Middle Aged | 3 | 2014 | 223737 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2004 | 2238 | 0.030 |
Why?
|
Intracellular Membranes | 1 | 1993 | 388 | 0.030 |
Why?
|
Valinomycin | 1 | 1991 | 17 | 0.020 |
Why?
|
Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 1991 | 20 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1993 | 657 | 0.020 |
Why?
|
Oligomycins | 1 | 1991 | 20 | 0.020 |
Why?
|
Binding Sites | 2 | 2014 | 6023 | 0.020 |
Why?
|
Sharks | 1 | 1991 | 21 | 0.020 |
Why?
|
HIV-1 | 1 | 2009 | 6962 | 0.020 |
Why?
|
Administration, Oral | 1 | 2000 | 4040 | 0.020 |
Why?
|
Cnidarian Venoms | 1 | 1991 | 19 | 0.020 |
Why?
|
Ionophores | 1 | 1991 | 108 | 0.020 |
Why?
|
Cell Cycle | 1 | 2000 | 2937 | 0.020 |
Why?
|
Proteolipids | 1 | 1991 | 112 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2014 | 450 | 0.020 |
Why?
|
Creatine Kinase | 1 | 1993 | 684 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2014 | 1216 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1683 | 0.020 |
Why?
|
Immunoglobulin G | 2 | 2007 | 4568 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 8664 | 0.020 |
Why?
|
Hemoglobins | 1 | 1996 | 1531 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2008 | 3775 | 0.020 |
Why?
|
Chlorides | 2 | 1991 | 666 | 0.020 |
Why?
|
Cytotoxins | 1 | 2011 | 154 | 0.020 |
Why?
|
Methazolamide | 1 | 1989 | 9 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1991 | 2488 | 0.020 |
Why?
|
Cytosol | 1 | 1993 | 886 | 0.020 |
Why?
|
Mice, SCID | 1 | 1995 | 2631 | 0.020 |
Why?
|
Protein Conformation | 2 | 2009 | 3956 | 0.020 |
Why?
|
Acrylamides | 1 | 1991 | 261 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2014 | 1952 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2011 | 5906 | 0.020 |
Why?
|
Thermolysin | 1 | 1989 | 14 | 0.020 |
Why?
|
Hypotonic Solutions | 1 | 1989 | 48 | 0.020 |
Why?
|
Apoptosis | 1 | 2005 | 9527 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 1996 | 2635 | 0.020 |
Why?
|
Kidney Transplantation | 1 | 2004 | 4265 | 0.020 |
Why?
|
Electrochemistry | 1 | 1989 | 146 | 0.020 |
Why?
|
Cations | 1 | 1989 | 240 | 0.020 |
Why?
|
Colloids | 1 | 1989 | 126 | 0.020 |
Why?
|
Potassium Chloride | 1 | 1989 | 229 | 0.020 |
Why?
|
Pyrans | 1 | 2009 | 49 | 0.020 |
Why?
|
Foam Cells | 1 | 2009 | 68 | 0.020 |
Why?
|
Osmotic Pressure | 1 | 1989 | 137 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2010 | 321 | 0.020 |
Why?
|
Streptococcus intermedius | 1 | 2007 | 4 | 0.020 |
Why?
|
Species Specificity | 2 | 2007 | 2417 | 0.020 |
Why?
|
Interferon-gamma | 1 | 1996 | 3163 | 0.020 |
Why?
|
Circular Dichroism | 1 | 2008 | 337 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 1993 | 1526 | 0.020 |
Why?
|
Ultrafiltration | 1 | 1988 | 48 | 0.020 |
Why?
|
Cations, Monovalent | 1 | 1987 | 24 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2010 | 462 | 0.020 |
Why?
|
Fluorenes | 1 | 2009 | 160 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1989 | 1142 | 0.020 |
Why?
|
Cell Separation | 1 | 1993 | 1728 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1994 | 1493 | 0.020 |
Why?
|
Fluorescence Polarization Immunoassay | 1 | 2007 | 9 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 1995 | 1356 | 0.020 |
Why?
|
Aged | 2 | 2014 | 171786 | 0.020 |
Why?
|
Angiotensin II | 1 | 2010 | 844 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 2010 | 769 | 0.020 |
Why?
|
Biological Transport, Active | 1 | 1987 | 323 | 0.020 |
Why?
|
Cell Extracts | 1 | 2007 | 135 | 0.020 |
Why?
|
Choroid Plexus | 1 | 1989 | 250 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2010 | 633 | 0.020 |
Why?
|
Neurons | 2 | 1997 | 9519 | 0.020 |
Why?
|
Lactates | 1 | 1987 | 401 | 0.020 |
Why?
|
Entropy | 1 | 2007 | 211 | 0.020 |
Why?
|
Carbon Isotopes | 1 | 2007 | 458 | 0.020 |
Why?
|
Fourier Analysis | 1 | 2007 | 441 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2010 | 2298 | 0.020 |
Why?
|
PC12 Cells | 2 | 1997 | 317 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2007 | 867 | 0.020 |
Why?
|
Type C Phospholipases | 2 | 1997 | 287 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2007 | 739 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2001 | 9549 | 0.020 |
Why?
|
Dogs | 1 | 1990 | 3845 | 0.020 |
Why?
|
Phosphatidylinositols | 2 | 1997 | 280 | 0.020 |
Why?
|
Adenosine Triphosphate | 2 | 1991 | 2003 | 0.020 |
Why?
|
Endothelium | 1 | 2007 | 768 | 0.020 |
Why?
|
Granulocytes | 1 | 2007 | 551 | 0.020 |
Why?
|
Risk Factors | 2 | 2024 | 74976 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 2 | 1997 | 412 | 0.010 |
Why?
|
Peptide Hydrolases | 1 | 1988 | 610 | 0.010 |
Why?
|
Perfusion | 1 | 1989 | 1402 | 0.010 |
Why?
|
Obesity | 1 | 1987 | 13091 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2000 | 4064 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 13055 | 0.010 |
Why?
|
Feedback, Physiological | 1 | 2007 | 481 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2011 | 945 | 0.010 |
Why?
|
von Willebrand Factor | 1 | 2007 | 680 | 0.010 |
Why?
|
Models, Animal | 1 | 2010 | 2122 | 0.010 |
Why?
|
Blood Proteins | 1 | 1989 | 1191 | 0.010 |
Why?
|
Polysaccharides | 1 | 2009 | 1024 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 1993 | 8144 | 0.010 |
Why?
|
Lactic Acid | 1 | 1987 | 1140 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 6232 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2007 | 1340 | 0.010 |
Why?
|
NF-kappa B | 1 | 2010 | 2492 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 1987 | 873 | 0.010 |
Why?
|
Oncogenes | 1 | 2007 | 1236 | 0.010 |
Why?
|
Dietary Fats | 1 | 2009 | 2002 | 0.010 |
Why?
|
Glycosylphosphatidylinositols | 1 | 2000 | 88 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2010 | 2080 | 0.010 |
Why?
|
DNA | 1 | 1994 | 7214 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2000 | 777 | 0.010 |
Why?
|
Restriction Mapping | 1 | 2000 | 849 | 0.010 |
Why?
|
Protein Sorting Signals | 1 | 2000 | 274 | 0.010 |
Why?
|
Prostaglandins F | 1 | 1979 | 80 | 0.010 |
Why?
|
p-Methoxy-N-methylphenethylamine | 1 | 1979 | 41 | 0.010 |
Why?
|
Probenecid | 1 | 1979 | 73 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2011 | 1642 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 30046 | 0.010 |
Why?
|
Ruthenium Red | 1 | 1978 | 19 | 0.010 |
Why?
|
Histamine Release | 1 | 1978 | 134 | 0.010 |
Why?
|
Isoproterenol | 1 | 1978 | 398 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39394 | 0.010 |
Why?
|
Metiamide | 1 | 1977 | 6 | 0.010 |
Why?
|
Methysergide | 1 | 1977 | 28 | 0.010 |
Why?
|
Receptors, Histamine H2 | 1 | 1977 | 18 | 0.010 |
Why?
|
Receptors, Histamine H1 | 1 | 1977 | 20 | 0.010 |
Why?
|
Drinking | 1 | 1978 | 196 | 0.010 |
Why?
|
Blood Physiological Phenomena | 1 | 1997 | 53 | 0.010 |
Why?
|
Complement C3b | 1 | 1997 | 98 | 0.010 |
Why?
|
Diphenhydramine | 1 | 1977 | 63 | 0.010 |
Why?
|
Cromolyn Sodium | 1 | 1977 | 78 | 0.010 |
Why?
|
Ascitic Fluid | 1 | 1977 | 189 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 7453 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 1997 | 6086 | 0.010 |
Why?
|
RNA | 1 | 2006 | 2727 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2749 | 0.010 |
Why?
|
Water-Electrolyte Balance | 1 | 1977 | 326 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12873 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2011 | 5342 | 0.010 |
Why?
|
Neoplasms | 1 | 2004 | 22389 | 0.010 |
Why?
|
Cell Count | 1 | 1978 | 1833 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8544 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2007 | 5151 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 81903 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4592 | 0.010 |
Why?
|
Inflammation | 1 | 1993 | 10868 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1997 | 2474 | 0.010 |
Why?
|
Cesium | 1 | 1991 | 36 | 0.010 |
Why?
|
Vanadates | 1 | 1991 | 82 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1989 | 7885 | 0.010 |
Why?
|
Cell Death | 1 | 1997 | 1682 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13674 | 0.010 |
Why?
|
Drug Combinations | 1 | 1997 | 2089 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15951 | 0.010 |
Why?
|
Hydrolysis | 1 | 1991 | 646 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 1995 | 13594 | 0.010 |
Why?
|
Sodium Channels | 1 | 1991 | 341 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2009 | 6569 | 0.000 |
Why?
|
Lithium | 1 | 1991 | 600 | 0.000 |
Why?
|
Magnesium | 1 | 1991 | 816 | 0.000 |
Why?
|
Cell Survival | 1 | 1995 | 5793 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1997 | 7609 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1995 | 11116 | 0.000 |
Why?
|